Drawing for NGSCOUNTER

USPTO serial 86251516

NGSCOUNTER

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
BAKER, JORDAN A
Law office
GENERIC WEB UPDATE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NGSCOUNTER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lorraine Linford

LORRAINE LINFORD SEED IP LAW GROUP PLLC701 5TH AVE STE 5400SEATTLE, WA 98104-7064UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Diagnostic preparations, except for human medicine and veterinary medicine purposes; reagents and solvents not for human medical and veterinary purposes, in particular for sample preparation, modification and manipulation of cells as well as for the performance of labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; kits consisting primarily of nucleic acid compounds, protein assays and chemical reagents, in particular for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids and proteins from biological material, all for other than human medicine and veterinary medicine purposesABANDONED—
005Diagnostic preparations for medical and veterinary use; products for human medicine and veterinary medicine purposes, in particular diagnostic preparations, in particular for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances; chemical biochemical and biotechnological products all for human medicine and veterinary medicine purposes, in particular reagents and solvents, in particular for sample preparation, modification and manipulation of cells as well as for the performance of labeling, separation, isolation, reproduction and purification methods for biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances for diagnostic purposes; kits consisting primarily of nucleic acid compounds, protein assays and chemical reagents for human medicine or veterinary medicine diagnostic purposes, in particular for sample preparation, modification and manipulation of cells as well as for labeling, separation, isolation, reproduction and purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids and proteins from biological materialABANDONED—
009Scientific apparatuses, instruments and equipment, namely, optical apparatuses and instruments for laboratory purposes, calculating machines, electrical and electronic apparatuses and instruments, in particular for research and analysis purposes in the field of molecular biology; laboratory equipment, measuring apparatuses and instruments, namely, robot manipulators, laboratory consumable dispensers, laboratory sample conditioners, namely, incubators, stirrers, mixers, dispensers, aspirators; laboratory and measuring apparatuses and instruments, namely filter systems for laboratory purposes, ultrafiltration devices and apparatuses, ultrafiltration membranes, chromatography apparatuses and instruments, ion exchanger apparatuses and instruments, laboratory concentrator devices; scientific apparatuses and instruments being laboratory equipment and single-use laboratory articles, in particular laboratory apparatuses for the processing of fluid samples, in particular apparatuses for dosing, transferring, mixing, tempering, concentrating, homogenizing and filtering of sample liquids and reagents for medical and veterinary medical diagnostic purposes, in particular for sample preparation, modification and manipulation of cells and for labeling, separation, isolation, reproduction and the purification of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids and proteins from biological materialABANDONED—
042Scientific and technological services, namely, research, development and diagnostics in the field of cancer treatment and diagnosis, treatment and diagnosis of viral and bacterial mediated diseases, treatment and diagnosis of diseases of the blood, treatment and diagnosis of diseases of the skin, treatment and diagnosis of diseases of the brain, treatment and diagnosis of diseases of the heart, treatment and diagnosis of diseases of the liver, treatment and diagnosis of diseases of the lungs; as well as design services, namely, work on and evaluation of chemical syntheses, in particular the synthesis of oligonucleotides, polynucleotides and proteinsABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 11, 2015MAB5ABANDONMENT NOTICE MAILED - AFTER PUBLICATION—
Jun 11, 2015ABN5ABANDONMENT - AFTER PUBLICATION—
Jun 9, 2015EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Apr 22, 2015ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Mar 24, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 24, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 4, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 13, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 12, 2015ALIEASSIGNED TO LIE—
Jan 26, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 24, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 23, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 23, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 24, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 24, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 24, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 23, 2014DOCKASSIGNED TO EXAMINER—
Apr 29, 2014MPMKNOTICE OF PSEUDO MARK E-MAILED—
Apr 28, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 17, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance